Hemangeol® Information For Healthcare Professionals

Helpful Resources

Patient Education Materials

hemangeol dosing chartHEMANGEOL
Dosing Chart

You can use this chart as a tool to instruct parents and caregivers on the proper dosing of HEMANGEOL.

Download Dosing Chart

HEMANGOL Instructions for Use
HEMANGEOL
Instructions for Use

Parents and caregivers can follow these simple instructions to learn how to properly administer HEMANGEOL.

Download Instructions

HEMANGEOL Patient BrochureHEMANGEOL
Patient Brochure

This brochure can answer common questions parents and caregivers may have about infantile hemangioma and HEMANGEOL.

Download Brochure

Download Spanish Brochure

HEMANGEOL Patient BrochureHEMANGEOL
Patient Brochure

This brochure can answer common questions parents and caregivers may have about infantile hemangioma and HEMANGEOL.

Download Brochure

Download Spanish Brochure

Hemangiom App Flyer

Hemangiom’App Guide

Hemangiom’App is a digitalization of the caregiver guide, designed to help you manage your infant’s treatment plan through support and guidance.

Download HEMANGIOM’ APP FLYER

Most Prescribed

HEMANGEOL is the most prescribed Infantile Hemangioma Treatment in America*.

Download Most Prescribed

Physician Education Materials

derm expert brochure for HemangeolDerm Expert

Brochure report showcasing the three types of Infantile Hemangioma, the evolution of the disease, and the sequelae after involution of untreated hemangiomas.

Download The Derm Expert Brochure

hemangeol brochureHEMANGEOL Guide 

Brochure discussing the indications, contraindications, how to prescribe, how to administer, duration of treatment, product characteristics, and more for HEMANGEOL.

Download HEMANGEOL Guide

what is infantile hemangioma brochureHEMANGEOL Patient Brochure

This brochure can answer common questions that parents and caregivers may have about infantile hemangioma and HEMANGEOL.

Download Patient Brochure Brochure

carrier informationHEMANGEOL
Alcohol Pediatric Guidelines

How much is too much when the pediatric minimal alcohol dose for toxicity is unknown? Guideline brochure for information. Free download.

Download Alcohol Pediatric Guidelines

Other Resources

Request a visit

If you would like additional information about HEMANGEOL, our dedicated representatives are available to answer your questions and provide you with the resources you need to educate parents and caregivers.

Find Support for Your Patients and Their Loved Ones

There are a number of advocacy groups dedicated to providing education and support to parents and caregivers of infantile hemangioma patients.

Video resources

Find videos about HEMANGEOL.

Published Data

DOSING ERRORS FOR HEMANGEOL VS GENERIC PROPRANOLOL HYDROCHLORIDE

In a 2017, the Journal of American Academy of Dermatology published a letter to the editor, “Prescribing propranolol for infantile hemangioma: Assessment of dosing errors,” showing results from an institutional review board-approved survey comparing the propensity for dispensing and dosing calculation errors of HEMANGEOL (propranolol hydrochloride oral solution 4.28 mg/mL) versus generic propranolol hydrochloride oral solutions (4 mg/mL and 8 mg/mL) during the treatment of infantile hemangiomas.

The survey of 220 pediatric dermatologists and other physicians who treat infantile hemangioma found that medication dispensing and calculation errors are very common among physicians prescribing generic propranolol hydrochloride vs. HEMANGEOL.

Article Source: https://www.jaad.org/article/S0190-9622(16)31183-5/fulltext

References
Prescribing errors with pediatric oral propranolol solutions. Reactions Weekly 1651, 12 (2017). https://doi.org/10.1007/s40278-017-29824-x

Request a Visit

If you are a healthcare professional in the United States and would like a HEMANGEOL representative to contact you, please complete the form below.

Caregiver Support and Patient Advocacy Groups

When a baby first develops an infantile hemangioma, parents and caregivers may experience feelings of confusion, anxiousness, and guilt.

Below is a list of organizations dedicated to providing education and support to all those affected by infantile hemangiomas.

The Vascular Birthmarks Foundation (VBF)
P.O. Box 106
Latham, NY 12110-0106
Phone: (877) 823-4646
Website: birthmark

The Vascular Birthmarks Foundation is an international charitable organization that connects families affected by vascular birthmarks, tumors, or syndromes to the appropriate medical professionals. The foundation also provides informational resources, sponsors physician education, facilitates medical mission trips, and supports research and programs that promote acceptance for individuals with birthmarks.

Video Resources

Early Diagnosis and Treatment of Infantile Hemangioma:
The New Paradigm of Care

What is Infantile Hemangioma?
How to use HEMANGEOL
To understand and treat the Infantile Hemangioma - Caregivers roles
The Hemangiom APP

Important Safety Information for HEMANGEOL
HEMANGEOL can cause serious side effects, including low blood sugar (hypoglycemia), for your child. Please read the important safety information for HEMANGEOL and speak with your doctor before taking HEMANGEOL.

Important Safety Information for HEMANGEOL

Do not give HEMANGEOL to your child if your child:

  • was born prematurely and has not reached the corrected age of 5 weeks
  • weighs less than 4 ½ pounds
  • is allergic to propranolol or any of the other ingredients in HEMANGEOL
  • has asthma or a history of breathing problems
  • has a heart problem, slow heart rate (less than 80 heart beats per minute), very low blood pressure
  • is at risk for low blood sugar, for example is vomiting or unable to take feedings
  • has high blood pressure caused by a tumor on the adrenal gland, called “pheochromocytoma”


Tell your doctor about all of your child’s medical conditions, all of the medicines your child takes, and all of the medicines that you take if you are breastfeeding your child.

HEMANGEOL can cause serious side effects, including:

Low blood sugar (hypoglycemia), especially if your child is not taking feedings, or is vomiting. HEMANGEOL may make it more difficult to recognize the signs and symptoms of low blood sugar in your child. To help reduce the risk of low blood sugar with HEMANGEOL, give HEMANGEOL during or shortly after feeding your child. Feed your child regularly during treatment. Tell your doctor if your child has a poor appetite. If your child is not taking feedings, due to an illness or vomiting, do not give HEMANGEOL until your child is taking feedings normally again.

If your child has any of the signs or symptoms of low blood sugar listed below during treatment with HEMANGEOL, stop giving your child HEMANGEOL and call your doctor or go to the nearest emergency room right away.

Signs or symptoms of low blood sugar include: pale, blue or purple skin color, sweating, irritability, crying for no apparent reason, irregular or fast heartbeat, poor feeding, low body temperature, unusual sleepiness, seizures, breathing stops for short periods of time, and loss of consciousness

If your child is conscious, give him/her a drink of a liquid containing sugar.

Other serious side effects can include:
  • New or worsening slow heart rate (bradycardia) or low blood pressure (hypotension).
  • Breathing problems or wheezing.
  • Stroke. HEMANGEOL may increase the risk of stroke in certain children who have severe problems with the blood vessels in their brain, particularly if your child has a large hemangioma that affects the face or head.


Call your doctor or go to the nearest hospital emergency room if your child has:

  • pale skin color, slow or uneven heartbeats, arms or legs feel cold, blue or purple skin color, or fainting.
  • breathing problems or wheezing during treatment with HEMANGEOL.


The most common side effects include:
 sleep problems, worsening respiratory tract infections, diarrhea, and vomiting.

These are not all the possible side effects of HEMANGEOL. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information and Medication Guide.